S&P 500   3,319.55 (-0.30%)
DOW   29,158.29 (-0.65%)
QQQ   222.92 (-0.21%)
AAPL   316.65 (-0.65%)
FB   221.02 (-0.50%)
MSFT   166.80 (-0.18%)
AMZN   1,867.25 (+0.14%)
NVDA   247.42 (-0.75%)
BABA   221.51 (-2.60%)
MU   58.66 (+1.73%)
GE   11.66 (-1.35%)
TSLA   541.63 (+6.10%)
AMD   50.77 (-0.31%)
T   38.59 (+0.55%)
F   9.18 (+0.22%)
NFLX   333.89 (-1.70%)
PRI   127.21 (-0.95%)
BAC   34.38 (-0.98%)
DIS   143.22 (-0.78%)
S&P 500   3,319.55 (-0.30%)
DOW   29,158.29 (-0.65%)
QQQ   222.92 (-0.21%)
AAPL   316.65 (-0.65%)
FB   221.02 (-0.50%)
MSFT   166.80 (-0.18%)
AMZN   1,867.25 (+0.14%)
NVDA   247.42 (-0.75%)
BABA   221.51 (-2.60%)
MU   58.66 (+1.73%)
GE   11.66 (-1.35%)
TSLA   541.63 (+6.10%)
AMD   50.77 (-0.31%)
T   38.59 (+0.55%)
F   9.18 (+0.22%)
NFLX   333.89 (-1.70%)
PRI   127.21 (-0.95%)
BAC   34.38 (-0.98%)
DIS   143.22 (-0.78%)
S&P 500   3,319.55 (-0.30%)
DOW   29,158.29 (-0.65%)
QQQ   222.92 (-0.21%)
AAPL   316.65 (-0.65%)
FB   221.02 (-0.50%)
MSFT   166.80 (-0.18%)
AMZN   1,867.25 (+0.14%)
NVDA   247.42 (-0.75%)
BABA   221.51 (-2.60%)
MU   58.66 (+1.73%)
GE   11.66 (-1.35%)
TSLA   541.63 (+6.10%)
AMD   50.77 (-0.31%)
T   38.59 (+0.55%)
F   9.18 (+0.22%)
NFLX   333.89 (-1.70%)
PRI   127.21 (-0.95%)
BAC   34.38 (-0.98%)
DIS   143.22 (-0.78%)
S&P 500   3,319.55 (-0.30%)
DOW   29,158.29 (-0.65%)
QQQ   222.92 (-0.21%)
AAPL   316.65 (-0.65%)
FB   221.02 (-0.50%)
MSFT   166.80 (-0.18%)
AMZN   1,867.25 (+0.14%)
NVDA   247.42 (-0.75%)
BABA   221.51 (-2.60%)
MU   58.66 (+1.73%)
GE   11.66 (-1.35%)
TSLA   541.63 (+6.10%)
AMD   50.77 (-0.31%)
T   38.59 (+0.55%)
F   9.18 (+0.22%)
NFLX   333.89 (-1.70%)
PRI   127.21 (-0.95%)
BAC   34.38 (-0.98%)
DIS   143.22 (-0.78%)
Log in
(Ad)
A brand-new technology - code named "Halo-Fi" - could kill off your overpriced cable company for good... beaming lightning-fast internet to your home for an estimated $7 a month.

This is undoubtedly the beginning of the end for "Big 3" internet providers.

Forward-thinking investors in Halo-Fi are lining up to get rich before January 30th.

NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

$26.39
+0.14 (+0.53 %)
(As of 01/21/2020 02:38 PM ET)
Today's Range
$26.32
Now: $26.39
$26.78
50-Day Range
$21.72
MA: $24.63
$26.25
52-Week Range
$16.68
Now: $26.39
$29.80
Volume3,526 shs
Average Volume51,597 shs
Market Capitalization$302.96 million
P/E Ratio39.99
Dividend YieldN/A
Beta1.56
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$30.44 million
Cash Flow$0.58 per share
Book Value$3.84 per share

Profitability

Net Income$6.30 million

Miscellaneous

Employees95
Market Cap$302.96 million
Next Earnings Date2/5/2020 (Estimated)
OptionableNot Optionable

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Each week, an exclusive group of investors receives access to a simple list of 3 stocks to put on their radar for the week ahead.

You can sign up today to receive access to next week's watchlist -- generated by a proprietary methodology -- at no cost or obligation.

Iradimed (NASDAQ:IRMD) Frequently Asked Questions

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) released its quarterly earnings results on Wednesday, October, 30th. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.13 by $0.07. The medical equipment provider had revenue of $9.96 million for the quarter, compared to the consensus estimate of $9.85 million. Iradimed had a return on equity of 16.24% and a net margin of 22.51%. View Iradimed's Earnings History.

When is Iradimed's next earnings date?

Iradimed is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Iradimed.

Has Iradimed been receiving favorable news coverage?

Headlines about IRMD stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Iradimed earned a daily sentiment score of 2.2 on InfoTrie's scale. They also assigned press coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Iradimed.

Are investors shorting Iradimed?

Iradimed saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 460,900 shares, an increase of 7.7% from the December 15th total of 428,000 shares. Based on an average trading volume of 67,700 shares, the days-to-cover ratio is currently 6.8 days. Approximately 8.5% of the shares of the company are short sold. View Iradimed's Current Options Chain.

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Palo Alto Networks (PANW), Gilead Sciences (GILD), BioTelemetry (BEAT), Alphabet (GOOG), IntriCon (IIN), Paypal (PYPL), Alibaba Group (BABA) and Mastercard (MA).

Who are Iradimed's key executives?

Iradimed's management team includes the folowing people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $26.39.

How big of a company is Iradimed?

Iradimed has a market capitalization of $302.96 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

What is Iradimed's official website?

The official website for Iradimed is http://www.iradimed.com/.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]


MarketBeat Community Rating for Iradimed (NASDAQ IRMD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  219 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  447
MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel